HEMATOPOETIC MYELODYSPLASIA

Clinical trials for HEMATOPOETIC MYELODYSPLASIA explained in plain language.

Never miss a new study

Get alerted when new HEMATOPOETIC MYELODYSPLASIA trials appear

Sign up with your email to follow new studies for HEMATOPOETIC MYELODYSPLASIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Scientists train Patients' own cells to hunt blood cancer

Disease control Recruiting now

This early-stage study is testing a new, personalized treatment for several types of blood cancer that are hard to treat. Doctors take a patient's own immune cells (T cells), genetically modify them in a lab to recognize and attack their specific cancer, and then infuse them back…

Matched conditions: HEMATOPOETIC MYELODYSPLASIA

Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 25, 2026 14:07 UTC

HEMATOPOETIC MYELODYSPLASIA

Get alerted when new HEMATOPOETIC MYELODYSPLASIA trials appear

Scientists train Patients' own cells to hunt blood cancer